Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Hemorrhage | 19 | 2024 | 2649 | 2.190 |
Why?
|
Cerebrovascular Disorders | 5 | 2020 | 1475 | 1.070 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2023 | 885 | 0.690 |
Why?
|
Stroke | 9 | 2024 | 9749 | 0.680 |
Why?
|
Hematoma | 3 | 2020 | 766 | 0.670 |
Why?
|
Arteriolosclerosis | 1 | 2019 | 21 | 0.660 |
Why?
|
Apolipoproteins E | 2 | 2024 | 1458 | 0.580 |
Why?
|
Genetic Predisposition to Disease | 9 | 2024 | 18064 | 0.580 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2018 | 416 | 0.540 |
Why?
|
Urinary Tract Infections | 3 | 2018 | 804 | 0.480 |
Why?
|
Sex Characteristics | 2 | 2024 | 2643 | 0.380 |
Why?
|
Dementia | 1 | 2024 | 2743 | 0.330 |
Why?
|
Pneumonia | 3 | 2018 | 2156 | 0.330 |
Why?
|
Sepsis | 2 | 2018 | 2603 | 0.270 |
Why?
|
Kidney | 1 | 2020 | 7073 | 0.230 |
Why?
|
Stress, Psychological | 1 | 2019 | 4528 | 0.220 |
Why?
|
Amaurosis Fugax | 1 | 2023 | 7 | 0.220 |
Why?
|
Genome-Wide Association Study | 7 | 2023 | 12800 | 0.220 |
Why?
|
Hypertension | 3 | 2021 | 8625 | 0.210 |
Why?
|
Aged, 80 and over | 16 | 2021 | 59506 | 0.180 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 20 | 0.170 |
Why?
|
Leukoaraiosis | 1 | 2020 | 114 | 0.160 |
Why?
|
Waist-Hip Ratio | 1 | 2020 | 520 | 0.150 |
Why?
|
Aged | 22 | 2024 | 171178 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2021 | 16040 | 0.150 |
Why?
|
Intracranial Hemorrhage, Hypertensive | 1 | 2017 | 19 | 0.150 |
Why?
|
Kidney Function Tests | 1 | 2020 | 684 | 0.150 |
Why?
|
Hematoma, Subdural, Intracranial | 1 | 2017 | 30 | 0.150 |
Why?
|
Obesity | 1 | 2020 | 13078 | 0.140 |
Why?
|
Ethylene Glycols | 1 | 2018 | 196 | 0.140 |
Why?
|
Mental Status Schedule | 2 | 2014 | 315 | 0.140 |
Why?
|
Cerebellar Diseases | 1 | 2019 | 227 | 0.130 |
Why?
|
Middle Aged | 20 | 2024 | 223016 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 12 | 2024 | 36542 | 0.130 |
Why?
|
Brain Ischemia | 2 | 2019 | 3001 | 0.130 |
Why?
|
Hypoalbuminemia | 1 | 2017 | 90 | 0.130 |
Why?
|
Humans | 34 | 2024 | 765823 | 0.130 |
Why?
|
Prospective Studies | 7 | 2024 | 54798 | 0.130 |
Why?
|
Male | 26 | 2024 | 363740 | 0.120 |
Why?
|
Cohort Studies | 5 | 2024 | 41643 | 0.120 |
Why?
|
Vasodilation | 1 | 2019 | 970 | 0.120 |
Why?
|
Linkage Disequilibrium | 1 | 2020 | 1996 | 0.120 |
Why?
|
Mutation | 1 | 2019 | 30188 | 0.120 |
Why?
|
Female | 26 | 2024 | 396050 | 0.120 |
Why?
|
Lymphopenia | 1 | 2017 | 298 | 0.120 |
Why?
|
Mendelian Randomization Analysis | 1 | 2020 | 1039 | 0.110 |
Why?
|
Serum Albumin | 1 | 2017 | 674 | 0.110 |
Why?
|
Neuropsychological Tests | 6 | 2016 | 7119 | 0.110 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 810 | 0.100 |
Why?
|
Health Behavior | 1 | 2024 | 2649 | 0.100 |
Why?
|
Aniline Compounds | 1 | 2018 | 1075 | 0.100 |
Why?
|
Genetic Loci | 1 | 2021 | 2631 | 0.100 |
Why?
|
Cholinesterase Inhibitors | 1 | 2014 | 241 | 0.100 |
Why?
|
Behavioral Symptoms | 1 | 2014 | 187 | 0.100 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1426 | 0.100 |
Why?
|
Longitudinal Studies | 5 | 2021 | 14745 | 0.090 |
Why?
|
Atrophy | 4 | 2020 | 1629 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2233 | 0.090 |
Why?
|
Ischemia | 1 | 2019 | 1922 | 0.090 |
Why?
|
Child Abuse | 1 | 2019 | 1090 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2393 | 0.090 |
Why?
|
Cognition Disorders | 2 | 2014 | 3966 | 0.080 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3894 | 0.080 |
Why?
|
Risk Factors | 5 | 2024 | 74853 | 0.080 |
Why?
|
Italy | 3 | 2016 | 851 | 0.080 |
Why?
|
Sex Factors | 2 | 2024 | 10607 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2019 | 4422 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2019 | 81505 | 0.070 |
Why?
|
Incidence | 1 | 2024 | 21501 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3815 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2307 | 0.060 |
Why?
|
Risk | 1 | 2018 | 9600 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4424 | 0.060 |
Why?
|
Blood Glucose | 1 | 2020 | 6422 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8224 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 22227 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8532 | 0.060 |
Why?
|
Genotype | 1 | 2018 | 13023 | 0.050 |
Why?
|
Temporal Lobe | 3 | 2015 | 1715 | 0.050 |
Why?
|
Brain | 4 | 2024 | 27178 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2015 | 3711 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 13041 | 0.050 |
Why?
|
Cerebral Cortex | 2 | 2015 | 5764 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5926 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2017 | 2844 | 0.050 |
Why?
|
Aging | 1 | 2019 | 8731 | 0.040 |
Why?
|
Diffusion Tensor Imaging | 2 | 2024 | 2415 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15881 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 24278 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3718 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20680 | 0.040 |
Why?
|
Australia | 1 | 2021 | 1259 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2015 | 6204 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2018 | 398 | 0.030 |
Why?
|
Perfusion | 1 | 2020 | 1408 | 0.030 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2019 | 519 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10570 | 0.030 |
Why?
|
Child | 2 | 2019 | 80509 | 0.030 |
Why?
|
United States | 2 | 2021 | 72896 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3427 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2020 | 1811 | 0.030 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2014 | 170 | 0.030 |
Why?
|
Triglycerides | 1 | 2020 | 2441 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2014 | 8725 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2018 | 832 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13613 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2014 | 913 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 2674 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2965 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8506 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1422 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2014 | 937 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7581 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3590 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2015 | 2415 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6014 | 0.020 |
Why?
|
Adult | 4 | 2024 | 223055 | 0.020 |
Why?
|
Genetic Variation | 1 | 2019 | 6607 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4036 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2014 | 2805 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6545 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 59849 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39226 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 30215 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 88794 | 0.010 |
Why?
|
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_